Alvogen Revenue and Competitors
Estimated Revenue & Valuation
- Alvogen's estimated annual revenue is currently $147.1M per year.
- Alvogen's estimated revenue per employee is $201,000
Employee Data
- Alvogen has 732 Employees.
Alvogen's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | VP Sales and Marketing | Reveal Email/Phone |
3 | EVP Sales/Marketing | Reveal Email/Phone |
4 | VP, U.S. 3rd Party Operations | Reveal Email/Phone |
5 | VP US Quality | Reveal Email/Phone |
6 | VP Analytical Services and Research & Development | Reveal Email/Phone |
7 | SVP, R&D | Reveal Email/Phone |
8 | Sr. VP Supply Chain | Reveal Email/Phone |
9 | VP- Business Development | Reveal Email/Phone |
10 | EVP | Reveal Email/Phone |
Alvogen Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4021M | 20005 | 9% | N/A | N/A |
#2 | N/A | 16258 | -2% | $30M | N/A |
What Is Alvogen?
Alvogen is a multinational, privately owned pharmaceuticals company focused on developing, manufacturing and distributing generic, brand, over-the-counter brands (OTC) and biosimilar products. With more than 200 pharmaceutical projects in development and registration, the group’s product portfolio consists of a broad range of leading molecules for the treatment of conditions in the fields of: oncology, cardiology, respiratory, neurology and gastroenterology. Alvogen has commercial operations in over 30 countries with 2,000 employees. North America is Alvogen’s single largest market and other key markets include: South-Korea, Romania, Bulgaria, Hungary, Taiwan, Russia and China.
keywords:N/A
N/A
Total Funding
732
Number of Employees
$147.1M
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator
Alvogen News
... Zydus Cadila, BioMarin, Catalyst Pharma, Novartis AG, Shenox Pharmaceuticals, LLC, Amneal Pharmaceuticals LLC, Alvogen, Apnar pharma.
Pfizer, Alvogen, Fresenius Kabi, West Ward Pharmaceutical, Sagent Pharmaceuticals, Mylan, FORWARD, CHANGCHUN LEI YUN SHANG PHARMACEUTICAL,...
... Accelerating Their Growth by Adapting New Trends | Actavis Inc., Alvogen Inc., Gland Pharma Limited, Sagent Pharmaceuticals Inc.,.
Premium A consortium of investors led by private equity firm CVC Capital Partners, that includes Singapore state fund Temasek, as well as Vatera Healthcare Partners have bought a controlling stake in pharmaceutical company Alvogen. Continue reading this story with a subscription to DealStreetA ...
Premium A consortium of investors led by private equity firm CVC Capital Partners, that includes Singapore state fund Temasek, as well as Vatera Healthcare Partners have bought a controlling stake in pharmaceutical company Alvogen. Continue reading this story with a subscription to DealStreetA ...